In this article, we will look at the 15 High Growth Stocks to Buy and Hold for the Next Decade.
High-growth stocks are getting more attention as investors look beyond the first wave of AI winners and try to identify companies that can still compound earnings over a longer period. The market has already rewarded many obvious leaders, but the next decade will depend more on finding businesses with durable demand, reinvestment capacity, and room to turn growth into profits.
BlackRock says “earnings are broadening beyond a highly concentrated group of mega-cap technology names tied to AI,” giving investors “greater choice for sourcing growth.” Capital Group makes a similar point, saying the market is moving toward a more balanced one with a broadening opportunity set, while noting that today’s AI leaders are supported by “solid earnings growth” and “strong free cash flow.” T. Rowe Price adds that AI could become the “biggest productivity driver since electricity,” but says investors should focus on “execution, financial resilience, and clear paths to monetization.”
Against this backdrop, high-growth stocks to buy and hold for the next decade deserve a closer look. The more interesting names are those tied to long-term demand, expanding earnings, and business models that can survive shifts in market sentiment. With that in mind, let’s take a look at the 15 High Growth Stocks to Buy and Hold for the Next Decade.
Our Methodology
We used the Finviz screener to identify high-growth stocks that are forecasted to grow their earnings by over 30% annually in the next 5 years. We then limited our final selection to companies that have recently reported noteworthy developments likely to impact investor sentiment. These stocks are also popular among analysts and elite hedge funds.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 498.7% since May 2014, beating its benchmark by 303 percentage points (see more details here).
15. Micron Technology, Inc. (NASDAQ:MU)
On May 22, 2026, Micron Technology, Inc. (NASDAQ:MU) announced the start of 1-alpha DRAM manufacturing at its Manassas, Virginia, fab, marking a step in the company’s efforts to expand domestic memory manufacturing capacity. Micron described the 1-alpha DRAM node as “the most advanced memory technology ever produced in the United States” and said the technology is suited for long-lifecycle memory products used in automotive, defense and aerospace, industrial, networking, and medical device applications. The company added that its more than $2B investment in the Manassas expansion and modernization project is supported by federal, state, and local incentives and supports more than 3,100 direct manufacturing and community jobs.
On May 19, 2026, Mizuho raised the firm’s price target on Micron Technology, Inc. to $800 from $740 and maintained an Outperform rating on the shares. The firm said channel checks continue to show AI server demand driving tailwinds across both NAND and DRAM markets, while supply is expected to remain tight into the first half of 2027. Mizuho also pointed to a potential Samsung strike as an additional supply risk factor.
A day earlier, Melius Research raised the firm’s price target on Micron (MU) to $1,100 from $700 and maintained a Buy rating on the shares. The firm said it remains “incrementally good” on memory and AI semiconductor makers and raised long-term estimates and price targets for several semiconductor names it described as “bottleneck stocks,” including Micron, Sandisk (SNDK), AMD (AMD), Intel (INTC), Marvell (MRVL), and Qualcomm (QCOM).
Micron Technology, Inc. designs, develops, manufactures, and sells memory and storage products internationally.
14. Marvell Technology, Inc. (NASDAQ:MRVL)
On May 22, 2026, Stifel raised the firm’s price target on Marvell Technology, Inc. (NASDAQ:MRVL) to $210 from $140 and kept a Buy rating on the shares. Nvidia partnership and hyperscaler capex raises reinforce the data center trajectory, says the analyst, who expects Marvell to deliver a beat when the company reports quarterly results.
Citi also raised the firm’s price target on Marvell to $215 from $118 and keeps a Buy rating on the shares ahead of the earnings report on May 27. The firm believes Trainium 2 ASIC demand remains strong. Citi cites its higher earnings expectations for the target boost.
Earlier, Wells Fargo raised the firm’s price target on Marvell to $195 from $135 and keeps an Overweight rating on the shares. While Marvell’s more than 30 times 2027 price-to-earnings certainly makes for a tougher set-up into Q1 2027 print, the firm sees AWS Trainium deploy, XPU-attach ramp, and continued Interconnect momentum as driving sufficient upside to support a bullish rating.
Marvell Technology, Inc., together with its subsidiaries, provides data infrastructure semiconductor solutions spanning the data center core to network edge in the United States, Argentina, China, India, Israel, Japan, Singapore, South Korea, Taiwan, Vietnam, and internationally.
13. Welltower Inc. (NYSE:WELL)
On May 21, 2026, Scotiabank raised the firm’s price target on Welltower Inc. (NYSE:WELL) to $248 from $236 and maintained an Outperform rating on the shares. Scotiabank said it was updating price targets for U.S. Real Estate & REITs under its coverage following Q1 results. The firm cited a “robust start” to the year for NYC office leasing, with broker checks pointing to strong tenant demand across alternative asset managers, banks, and tech firms. For multifamily, Scotiabank noted that rent growth has been mixed across the Sunbelt, with most markets still below 2015-2019 occupancy levels.
Jefferies analyst Jonathan Petersen also raised the firm’s price target on Welltower Inc. to $248 from $237 and maintained a Buy rating on the shares. Jefferies adjusted its estimates after the company’s Q1 earnings report and guidance raise.
Last month, Welltower Inc. reported Q1 normalized FFO of $1.47, ahead of the consensus estimate of $1.45. Revenue totaled $3.35B, above the consensus estimate of $3.2B. The company also reported total portfolio year-over-year SSNOI growth of 16.4%, driven by 22.1% SSNOI growth in its Seniors Housing Operating portfolio.
Welltower Inc. focuses on rental housing for aging seniors across the United States, the United Kingdom, and Canada.
12. Vertiv Holdings Co (NYSE:VRT)
On May 21, 2026, Roth Capital analyst Justin Clare raised the firm’s price target on Vertiv Holdings Co (NYSE:VRT) to $355 from $335 and maintained a Buy rating on the shares. Following the company’s Analyst Day, Clare came away incrementally more positive, citing the material increase in management’s five-year framework and Vertiv’s target for organic revenue CAGR of 20% to 22% over the next four years.
Oppenheimer analyst Noah Kaye also raised the firm’s price target on Vertiv Holdings Co to $353 from $330 and maintained an Outperform rating on the shares. Kaye said the company’s Investor Conference Day 2 highlighted a differentiated value proposition tied to faster innovation cycles, scale, breadth of offerings, and domain expertise that can drive systems-level efficiency gains. Oppenheimer also said Vertiv’s ability to increase wallet share from the current mix-weighted $3.25-$3.75/MW level points to upside versus 2030 targets.
Earlier, TD Cowen analyst Lance Vitanza raised the firm’s price target on Vertiv Holdings Co to $387 from $347 and maintained a Buy rating on the shares. Vitanza noted that the company left 2026 guidance unchanged and updated its long-term guide, including a 20%-22% five-year organic revenue growth CAGR and more than 27% AOM by 2030. TD Cowen views the long-term guide for both revenue and AOM as conservative.
Vertiv Holdings Co designs, manufactures, and services critical digital infrastructure technologies and life cycle services for data centers, communication networks, and commercial and industrial environments globally.
11. Freeport-McMoRan Inc. (NYSE:FCX)
On May 21, 2026, Barclays initiated coverage of Freeport-McMoRan Inc. (NYSE:FCX) with an Overweight rating and a $77 price target. Barclays analyst Richard Garchitorena said investments in “transformative” technologies and higher trade barriers are driving renewed growth across metals and mining. Garchitorena cited copper, rare earths, and uranium as key beneficiaries of that backdrop, while naming Freeport-McMoRan (FCX), Steel Dynamics (STLD), and MP Materials (MP) as the firm’s preferred stock ideas. Barclays also expects copper demand to outpace supply through the end of the decade and sees steel prices continuing to move higher in 2026.
Meanwhile, UBS analyst Daniel Major raised the firm’s price target on Freeport-McMoRan Inc. to $75 from $74 and maintained a Buy rating on the shares.
Last month, Freeport-McMoRan Inc. reported Q1 adjusted EPS of 57c, ahead of the consensus estimate of 47c. Revenue totaled $6.23B, above the consensus estimate of $5.96B. President and CEO Kathleen Quirk said the results reflected the strength of the company’s “diversified portfolio,” with revenue, cash flow, and earnings growth compared with the prior-year quarter despite reduced capacity at its Indonesia operations. Quirk added that Freeport is focused on restoring operations at Grasberg, improving profitability in the Americas, and pursuing organic growth options, while calling the company “America’s Copper Champion.”
Freeport-McMoRan Inc. engages in the mining of mineral properties in North America, South America, and Indonesia.
10. Bloom Energy Corporation (NYSE:BE)
On May 22, 2026, Daiwa upgraded Bloom Energy Corporation (NYSE:BE) to Outperform from Hold with a $324 price target. Daiwa said Bloom Energy is seeing an inflection in orders, capacity, and margins.
On May 20, 2026, Nebius and Bloom Energy Corporation announced an agreement to deploy Bloom’s fuel cell technology to help power Nebius’s AI infrastructure build-out. Bloom’s fuel cell systems will provide behind-the-meter electricity for Nebius and support demand for compute capacity tied to its full-stack AI cloud platform. The first project, with 328 MW of installed capacity, is expected to be operational this year and will eliminate the need for gas turbines at the site.
Last month, Bloom Energy Corporation reported Q1 EPS of 44c, above the consensus estimate of 13c. Revenue totaled $751.1M, ahead of the consensus estimate of $540.0M. Founder, Chairman, and CEO KR Sridhar said Bloom is becoming the “go-to choice” for on-site power, while CFO Simon Edwards cited the company’s differentiated technology, strategy, and focus on disciplined execution.
Bloom Energy Corporation designs, manufactures, sells, and installs solid oxide fuel cell systems for on-site power generation in the United States and internationally.
9. Vistra Corp. (NYSE:VST)
On May 21, 2026, Morgan Stanley raised the firm’s price target on Vistra Corp. (NYSE:VST) to $212 from $208 and maintained an Overweight rating on the shares. Morgan Stanley said it updated price targets for North American Regulated & Diversified Utilities / IPPs for April and noted that utilities underperformed the S&P’s return this month.
On May 12, 2026, JPMorgan also raised the firm’s price target on Vistra Corp. to $93 from $89 and maintained an Overweight rating on the shares.
Earlier in May, Vistra Corp. reported Q1 revenue of $5.64B, above the consensus estimate of $5.24B. The company also reported Q1 ongoing operations adjusted EBITDA of $1.49B. President and CEO Jim Burke said Vistra had an “exciting start to 2026,” citing plans to acquire the 5,500-MW Cogentrix natural gas generation portfolio and long-term power purchase agreements with Meta at its PJM nuclear sites. Burke also pointed to fleet performance during volatile winter weather, the mild first quarter in Texas for the retail business, and Fitch’s upgrade of Vistra’s corporate credit rating to Investment Grade.
Vistra Corp. operates as an integrated retail electricity and power generation company in the United States.
8. Block, Inc. (NYSE:XYZ)
On May 19, 2026, Canaccord analyst Joseph Vafi raised the firm’s price target on Block, Inc. (NYSE:XYZ) to $85 from $80 and maintained a Buy rating on the shares. Vafi said Block delivered solid Q1 results, with no adverse effects showing up a quarter after the company announced a roughly 40% workforce reduction as it leaned into AI. Canaccord added that, against a tough macro backdrop and maturing e-commerce payments, Block’s results showed that focus and strategy were paying off.
Goldman Sachs also raised the firm’s price target on Block, Inc. to $95 from $86 and maintained a Buy rating on the shares. Goldman Sachs said Block delivered a solid top- and bottom-line beat, with Square and Cash App gross profit ahead of expectations and operating expenses meaningfully lower due to headcount reductions. The firm also cited improving volume growth, customer acquisition, and retention at Square, continued momentum at Cash App, and execution tied to AI, the seller ecosystem, and its U.S. consumer neobank strategy.
Earlier in May, Block, Inc. reported Q1 adjusted EPS of 85c, ahead of the consensus estimate of 68c. Revenue totaled $6.06B, above the consensus estimate of $6.03B. In its quarterly letter, Block said year-over-year gross profit growth accelerated to 27%, while adjusted operating income margin reached an “all time high” of 25%. The company also said it now expects 19% year-over-year gross profit growth in 2026, an adjusted operating income margin of 27%, and adjusted diluted EPS growth of 62%.
Block, Inc. builds ecosystems focused on commerce and financial products and services in the United States and internationally.
7. TKO Group Holdings, Inc. (NYSE:TKO)
In a regulatory filing, TKO Group Holdings, Inc. (NYSE:TKO) disclosed that director Jonathan Kraft bought 5,200 shares of common stock on May 14 in a transaction valued at $988K.
On May 4, 2026, Roth Capital lowered the firm’s price target on TKO Group Holdings, Inc. to $228 from $260 and maintained a Buy rating on the shares ahead of the company’s Q1 results. Roth said TKO continues to benefit from recurring media rights contracts, growing partnerships and financial incentive packages, and long-term upside opportunities tied to Zuffa Boxing. The firm lowered its target to reflect market valuation pressures and noted uncertainty around whether TKO will hold planned UFC and WWE events in the Middle East this year while the conflict in Iran continues to evolve.
Earlier in May, TKO Group Holdings, Inc. reported Q1 EPS of $1.12, versus the consensus estimate of $1.14. Revenue totaled $1.60B, compared to the consensus estimate of $1.59B. Executive Chair and CEO Ariel Emanuel said TKO was off to a “formidable start” in 2026 and pointed to continued momentum across its businesses. President and COO Mark Shapiro said the results reflected the “strength and durability” of TKO’s premium IP, supported by media rights, financial incentive packages, and demand for live events and experiences. TKO also affirmed FY26 revenue guidance of $5.675B-$5.775B, compared to the consensus estimate of $5.78B, and affirmed FY26 adjusted EBITDA guidance of $2.24B-$2.29B, versus $1.59B in FY25.
TKO Group Holdings, Inc. operates as a sports and entertainment company through its UFC, WWE, and IMG segments.
6. Intel Corporation (NASDAQ:INTC)
On May 20, 2026, Intel Corporation (NASDAQ:INTC) was reported to be asking its leading PC partners across the U.S., China, and Taiwan to use more 18A CPUs, according to Nikkei Asia’s Lauly Li and Cheng Ting-Fang. The report said Intel cited better supply availability for chips built on the 18A node compared to older manufacturing nodes.
On May 18, 2026, Benchmark analyst Cody Acree raised the firm’s price target on Intel Corporation to $140 from $105 and maintained a Buy rating on the shares. Acree said the firm came away from a recent fireside chat with Intel “more constructive” on the durability of the company’s recovery and believes investors may still be underestimating Intel’s FY27-FY28 earnings power. The firm added that investor focus has shifted toward converting constrained demand as 18A, Intel 3, advanced packaging, ASIC, and external foundry capacity continue scaling.
Citi analyst Atif Malik also raised the firm’s price target on Intel Corporation to $130 from $95 and maintained a Buy rating on the shares. Citi introduced a new CPU total addressable market model covering general-purpose CPUs, AI head nodes, and agentic CPU applications. The firm now expects the market to grow 35% annually to $132B by 2030, driven by 185% annual growth in agentic CPUs.
Intel Corporation designs, develops, manufactures, markets, sells, and services computing and related products and services internationally.
5. Roivant Sciences Ltd. (NASDAQ:ROIV)
On May 21, 2026, TD Cowen raised the firm’s price target on Roivant Sciences Ltd. (NASDAQ:ROIV) to $41 from $38 and maintained a Buy rating on the shares. TD Cowen said IMVT-1402 toplined impressive Ph2b D2T RA data, with ACR20 of 73%, ACR50 of 55%, and ACR70 of 36%. The firm also said Roivant has many more catalysts ahead.
Citi also raised the firm’s price target on Roivant Sciences Ltd. to $42 from $35 and maintained a Buy rating on the shares. Citi said it sees further upside from Roivant’s second half of 2026 data catalysts and kept the stock as a top pick following the IMVT-1402 data.
A day earlier, Roivant Sciences Ltd. reported fiscal Q4 EPS of 28c, compared to the consensus estimate of (35c). Revenue totaled $2.52M, versus the consensus estimate of $3.91M. CEO Matt Gline said the positive Period 1 data from the IMVT-1402 trial in D2T RA showed “exciting potential” for a new treatment approach in RA patients who have failed multiple prior therapies. Gline also pointed to the FDA’s Breakthrough Therapy Designation for brepocitinib in cutaneous sarcoidosis and said the company expects several second-half 2026 updates, including brepocitinib’s expected launch in DM by the end of September and data in NIU, CLE, PH-ILD, and D2T RA.
Roivant Sciences Ltd. focuses on the discovery, development, and commercialization of medicines and technologies.
4. Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
On May 21, 2026, Bernstein analyst Jeffrey Walch initiated coverage of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) with an Outperform rating and a $221 price target. Walch said Neurocrine is one of the more promising investments within Bernstein’s initial coverage group of mid-cap biopharmaceutical companies, noting that the company’s two key medicines are already approved and have a long runway until loss-of-exclusivity. Bernstein added that upside exists to the current share price as the market gains more certainty around future market share and a potential positive Phase 3 trial readout.
Neurocrine Biosciences, Inc. announced new data from a clinician survey on patients with mild tardive dyskinesia, or TD, and treatment with INGREZZA, or valbenazine, capsules in a real-world setting. In a subgroup analysis, nearly all patients with clinician-reported mild TD treated with INGREZZA had fewer uncontrolled movements, with most showing symptom improvement within four weeks. The findings were presented at the American Psychiatric Association 2026 Annual Meeting, held May 16-20 in San Francisco. The analysis was based on clinician survey data covering TD symptoms, functional impairment, and improvement after INGREZZA treatment. Before treatment, clinicians reported that mild TD movements affected functional status in 90% of patients and independence in 84% of patients. After INGREZZA was started, 86% of patients with improved uncontrolled movements showed improvement in four weeks or less. Clinicians also reported improvement in more than 90% of impacted patients across functional areas, including speech, dexterity, social status, emotional status, and activities of daily living.
Neurocrine Biosciences, Inc. discovers, develops, and commercializes pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally.
3. American Healthcare REIT, Inc. (NYSE:AHR)
On May 22, 2026, BofA raised the firm’s price target on American Healthcare REIT, Inc. (NYSE:AHR) to $67 from $63 and maintained a Buy rating on the shares. BofA said it updated price targets on several REITs after reviewing its models.
On May 20, 2026, American Healthcare REIT, Inc. announced an underwritten public offering of 14M shares of common stock. The 14M-share spot secondary offering was priced at $50.40, below the prior closing price of $51.68. BofA Securities is acting as the underwriter for the offering.
Earlier in May, American Healthcare REIT, Inc. reported Q1 normalized FFO of 50c, ahead of the consensus estimate of 47c. Revenue totaled $650.77M, below the consensus estimate of $687.04M. CEO Jeff Hanson said the quarter reflected an “exceptionally strong period” across core metrics, including the company’s ninth consecutive quarter of double-digit Same-Store NOI growth, efficient capital formation and deployment, a strengthened balance sheet, and a raise to full-year 2026 Same-Store NOI growth and NFFO per share guidance.
American Healthcare REIT, Inc. owns and operates a diversified portfolio of clinical healthcare real estate across the U.S., U.K., and the Isle of Man.
2. Silicon Motion Technology Corporation (NASDAQ:SIMO)
On May 20, 2026, Silicon Motion Technology Corporation (NASDAQ:SIMO) announced that it achieved ISO 26262 functional safety process certification for automotive applications. The company said ISO 26262 sets requirements for the development and validation of automotive electrical and electronic systems, and said the certification reflects its investment in “automotive-grade engineering excellence” and support for safe, reliable storage technologies used in next-generation vehicles.
On May 12, 2026, B. Riley raised the firm’s price target on Silicon Motion Technology Corporation to $312 from $250 and maintained a Buy rating on the shares. B. Riley said AI investment is accelerating faster than expected, with demand from hyperscalers and neo-cloud providers driving higher 2026-2028 capital expenditure estimates. The firm also cited tightening supply-demand fundamentals, strong semiconductor EPS revisions, and elevated sector valuations despite recent volatility.
Last month, Silicon Motion Technology Corporation reported Q1 non-GAAP EPS of $1.58, compared to $1.26 in the last quarter. Revenue totaled $342.1M, compared to $278.5M in the previous quarter. President and CEO Wallace Kou said the results exceeded revenue, gross margin, and operating margin expectations, driven mainly by growth in embedded eMMC & UFS controllers and Ferri and boot drive solutions. Kou also said MonTitan will enter volume commercial production in the current quarter, earlier than planned, while customers expect to ramp five tier-one CSPs in the second half of the year.
Silicon Motion Technology Corporation designs, develops, and markets NAND flash controllers for solid-state storage devices and related devices internationally.
1. NVIDIA Corporation (NASDAQ:NVDA)
On May 20, 2026, NVIDIA Corporation (NASDAQ:NVDA) CEO Jensen Huang said the company has “largely conceded” China’s AI chip market to Huawei as U.S. export restrictions continue reshaping the global semiconductor landscape. Speaking to CNBC’s Sara Eisen, Huang said demand in China remains significant but described Huawei as “very, very strong,” adding that local Chinese chip companies are performing well “because we’ve evacuated that market.” Huang also said Huawei likely faces “an extraordinary year coming up.”
Also on May 20, NVIDIA Corporation reported Q1 adjusted EPS of $1.87, ahead of the consensus estimate of $1.77. Revenue totaled $81.6B, above the consensus estimate of $79.12B. Huang said the buildout of AI factories is “accelerating at extraordinary speed,” while pointing to the rapid scaling of agentic AI across industries. Huang added that Nvidia remains positioned “at the center of this transformation” through its AI infrastructure platform spanning hyperscale data centers and edge deployments.
Following the earnings report, Raymond James raised the firm’s price target on NVIDIA Corporation to $330 from $323 and maintained a Strong Buy rating on the shares. The firm said Nvidia delivered stronger-than-expected Q1 results and Q2 guidance, driven by inference-led growth and market share gains. Raymond James also highlighted the company’s new $80B buyback authorization and dividend increase from 1c to 25c per share.
NVIDIA Corporation operates as a data center-scale AI infrastructure company through its Compute & Networking and Graphics segments.
READ NEXT: 10 AI Stocks with Potential to Rise 1000 Percent and 9 Best American Semiconductor Stocks to Buy According to Analysts
